Organon to Acquire Turku-based Forendo Pharma
A global healthcare company Organon and Forendo Pharma have announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo. Forendo is pioneering the translation of intracrinology science into first-in-class therapeutic solutions. Forendo’s lead clinical compound in endometriosis is being evaluated for its potential effect on endometriotic lesions, a significant … Continued